| WORKSHOP: PARVOVIRUS B19 - IMPLICATIONS
FOR TRANSFUSION MEDICINE |
|
December 16,
1999 |
|
| Natcher
Auditorium |
National Institutes of
Health |
Bethesda, MD |
| This workshop will provide a
forum for topics related to the impact of Parvovirus B19 on transfusion
practice, including the frequency of human Parvovirus B19 viremia in blood
donors, the potential clinical consequences of transfusion-associated B19
infection, and issues about whether or not blood units should be screened for
B19. |
|
|
|
|
Agenda |
|
| Moderators: Harvey Klein and Margot
Kruskall |
| 8:20 a.m. |
Introduction |
Barbara Alving |
| 8:30 -
10:00 |
Human Parvovirus B19: Epidemiology and
Pathology |
Kevin Brown |
|
Hematology and Immunology of B19 Infection |
Neal Young |
| 10:00 -10:30 |
Discussion |
|
| 10:30 - 12:00 |
Testing (NAT, IgM/IgG) |
Larry Anderson |
|
Diagnosis |
Bernard Cohen |
| 12:00 - 12:30 |
Discussion |
|
| 12:30 - 1:30 |
Lunch |
|
| 1:30 - 3:00 |
Blood-borne B19:
Contamination of plasma
pools |
Bernard Horowitz |
|
Parvovirus infection following plasma exchange
using solvent-
detergent treated pooled plasma containing parvovirus |
Ted Eastlund |
|
Blood donors |
Roger Dodd |
|
Blood recipients |
Naomi Luban |
| 3:00 - 3:30 |
Discussion |
|
| 3:30 - 5:00 |
Directions for future research |
Panel discussion |
